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The mammalian circadian clock is composed of interlocking feedback
loops. Cryptochrome is a central component in the core negative
feedback loop, whereas Rev-Erbα, a member of the nuclear receptor
family, is an essential component of the interlocking loop. To un-
derstand the roles of different clock genes, we conducted a genetic
interaction screen by generating single- and double-mutant mice.
We found that the deletion of Rev-erbα in F-box/leucine rich-repeat
protein (Fbxl3)-deficient mice rescued its long-circadian period phe-
notype, and our results further revealed that FBXL3 regulates Rev-
Erb/retinoic acid receptor-related orphan receptor-binding element
(RRE)-mediated transcription by inactivating the Rev-Erbα:histone
deacetylase 3 corepressor complex. By analyzing the Fbxl3 and Cryp-
tochrome 1 double-mutant mice, we found that FBXL3 also regulates
the amplitudes of E-box–driven gene expression. These two sepa-
rate roles of FBXL3 in circadian feedback loops provide a mechanism
that contributes to the period determination and robustness of
the clock.
Circadian rhythms control many physiological processes in al-most all eukaryotic organisms (1–6). The current mammalian
clock model comprises a core negative feedback loop that
includes the Per-Arnt-Sim (PAS) domain-containing helix–loop–
helix transcription factors Clock and Bmal1, Period genes (Per1,
Per2, and Per3), and Cryptochrome genes (Cry1 and Cry2). The
CLOCK:BMAL1 complex activates the transcription of the
Period and Cryptochrome genes by binding to E-boxes in their
promoters, whereas the PER:CRY complex closes the negative
feedback loop by repressing the activity of CLOCK:BMAL1,
resulting in endogenous circadian oscillations of Per and Cry
mRNA (3, 5, 7). The nuclear receptors Rev-Erbα and RORα are
components of another feedback loop that is interlocked with the
core negative loop. These receptors function by competitively
binding to the Rev-Erb/ROR-binding element (RRE) of Bmal1
to regulate its rhythmic transcription (8–10).
Mutation of FBXL3 (C358S or I364T), a component of a SKP1–
CUL1–F-box (SCF) E3 ubiquitin ligase complex, results in ∼26-h-
period phenotypes in mice, indicating that FBXL3 plays an im-
portant role in circadian period determination (11–13). Previous
studies showed that FBXL3 interacts with CRY1 and CRY2,
promoting the degradation of both these proteins by the ubiquitin/
proteasome system, thus contributing to period length determi-
nation (11–13). However, overexpression of CRY1 protein does not
lead to period alteration (14), suggesting that the Fbxl3 mutation
might affect additional clock components.
To gain further insights into the mammalian clock network, we
studied the genetic interactions between different clock genes
in the mouse. Our screens revealed an unexpected genetic in-
teraction between Rev-erbα and Fbxl3. Further biochemical
analysis showed that FBXL3 regulates the Rev-Erbα–dependent
histone deacetylase 3 (HDAC3) repressor complex, suggesting
that the action of FBXL3 on Rev-Erbα:HDAC3 is crucial for
clock function. Our study further suggested that FBXL3 plays
an important role in coordinating E-box and RRE-mediated
transcription to modulate the circadian period and robustness
of the clock.
Results
Fbxl3 Genetically Interacts with Rev-erbα. To investigate the genetic
interactions between different clock genes, we obtained Clock
mutant mice (15), Bmal1-knockout mice (16), PER2S662G and
PER2S662D mice (17), Fbxl3 mutant Overtime (Ovtm) mice (11),
and Rev-erbα–knockout mice (8), and generated Cry1- and Cry2-
knockout mice by homologous recombination as described pre-
viously (18, 19). Then, a series of double-mutant mice were
generated, and their circadian locomotor activities were exam-
ined. We used the formula τpredicted = τx + τy − τwild type (where
τx and τy represent the τ of the single-mutant mice) to predict
the τ of the double-mutant mice and determine whether there
was genetic interplay between the different mutations. Using
this criterion, most of these clock genes did not appear to have
strong genetic interactions (Fig. S1). The period lengths for
Ovtm/Ovtm (11) and Rev-erbα−/− mutant mice (8) were 26.4 ±
0.1 h and 23.4 ± 0.4 h, respectively. Interestingly, we found that
the Ovtm/Ovtm;Rev-erbα−/− double-mutant mice exhibited a period
close to that of the Rev-erbα single-mutant mice (23.8 ± 0.4 h) (Fig.
1A), suggesting that the long-period phenotype caused by the
Ovtm mutation was rescued in the Rev-erbα-null background.
The Ovtm/Ovtm mice carry mutant alleles of the Fbxl3 gene
(11). To fully understand the role of Fbxl3, we generated con-
ditional Fbxl3-knockout (Fbxl3−/−) mice (Fig. S2) and Fbxl3-null
mice were developed by breeding with transgenic mice carrying
the Cre-recombinase gene under the control of the adenovirus
EIIa promoter. The heterozygous Fbxl3+/− mice exhibited a pe-
riod length of 24.42 h ± 0.1 h, which was 0.7 h longer than that of
their wild-type littermates. The homozygous Fbxl3−/− mice
exhibited a period of 27.60 ± 0.1 h, which was 1 h longer than
that of the Ovtm or Afterhour mice (Fig. 1B) (11, 12). We then
compared the levels of FBXL3 proteins in the wild-type and
Ovtm/Ovtm liver tissues and found dramatically reduced levels of
the mutant FBXL3 proteins (Fig. S3), suggesting that FBXL3
abundance is critical for period length in vivo. As expected, the
Fbxl3−/−;Rev-erbα −/− double-mutant mice also exhibited a period
near that of Rev-erbα−/− mice (23.7 ± 0.4 h, n = 20 vs. 23.4 ±
0.4 h, n = 8, P = 0.05) (Fig. 1 B and C), even though the Fbxl3-
knockout mice had an even longer period than that of the Ovtm/
Ovtm mice. These results suggest that the deletion of Rev-erbα
masks the defects of Fbxl3 knockout and that Rev-Erbα lies
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downstream of FBXL3 in a common circadian pathway. Of note,
the Fbxl3−/−;Rev-erbα−/− mice showed an unstable onset of activity
compared with the onset of activity in the wild-type mice (Fig. 1B
and Fig. S4), and 10% (2/20) of the double-mutant mice became
arrhythmic after 2–3 wk in constant darkness (DD) (Fig. S4). These
observations indicated that these two clock proteins play important
roles in regulating the robustness and stability of the clock.
Deletion of Rev-erbα Does Not Rescue Impaired CRY Degradation in
Fbxl3−/− Mice. Previous studies have revealed that FBXL3 regu-
lates the stability of CRYs, and the increased accumulation of
CRYs in Fbxl3 mutant mice could potentially explain their long-
period phenotype (11–13). We therefore asked whether the
rescue of the circadian period in the Fbxl3−/−;Rev-erbα−/− mice
was due to reduction of CRY levels to near wild-type levels. To
examine the levels of different clock proteins, we generated anti-
bodies against the mouse BMAL1, CRY1, and FBXL3 proteins.
These antibodies strongly detect the target proteins (Fig. S5). The
total level of CRY1 protein was modestly elevated in Fbxl3−/−
mice compared with wild-type mice as described previously (11)
(Fig. 2 A and B). The levels of both BMAL1 and CRY1 proteins
were significantly increased in the Fbxl3−/−;Rev-erbα−/− double-
mutant mice (Fig. 2 C and D), indicating that the rescue of the
circadian period in Fbxl3−/− mice via the deletion of Rev-erbα
was not due to a reduction in CRY1 abundance.
Then, we examined the binding of CRY1 protein to the E-box
regions of Per2 and Cry1 over a circadian cycle in liver tissues
using chromatin immunoprecipitation (ChIP) assays. In wild-type
tissues, the binding of CRY1 proteins to both the E-box regions
exhibited circadian rhythmicity. However, CRY1 binding to the
E-box region from circadian time (CT)12 to CT20 was consid-
erably higher in Fbxl3−/− mice compared with their wild-type
littermates (Fig. 3A). Furthermore, the immunoprecipitation
assays showed that there was little interaction between CRY1
and FBXL3 from CT12 to CT20 in wild-type tissues (Fig. 3B),
likely due to FBXL3-mediated CRY1 degradation. Again, the level
of CRY1 binding to the E-box regions in the Fbxl3−/−;Rev-erbα−/−
double-mutant mice was similar to that in Fbxl3−/− mice (Fig. 3A),
showing that the rescued period length in Fbxl3−/−;Rev-erbα−/−
mice was not due to reductions in CRY protein levels or its re-
duced binding to the E-box regions. To determine the activity of
CRY1 on the E-box, we examined the binding of RNA polymerase
II (RNAPII) to the Per1 and Per2 promoters to assay for dynamic
changes of transcriptional activity (20). Consistent with CRY1 ac-
cumulation, the RNAPII binding signals were substantially lower in
Fbxl3−/−;Rev-erbα−/− and Fbxl3−/− liver tissues (Fig. S6).
Dampened E-box–Driven Gene Expression in the Fbxl3−/−;Rev-erbα−/−
Mice Are CRY1 Dependent. It was previously reported that the
rhythms of circadian gene transcripts are severely dampened in
the Fbxl3 mutant mice (11). We examined the mRNA levels of
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Fig. 1. Representative actograms of locomotor activity in established mice
across the circadian day. Mice were entrained in light/dark 12:12 (LD) for
7–10 d and then released into constant darkness (DD) thereafter. LD-to-DD
transition is indicated by a horizontal bar. Black lines represent the phase
of activity onset in DD. (A) Wild-type (WT) (n = 8), Ovtm/Ovtm (n = 12),
Rev-erbα−/− (n = 8), and Rev-erbα−/−;Ovtm/Ovtm (n = 8). (B) Fbxl3−/− (n = 15)
and Fbxl3−/−;Rev-erbα−/− (n = 20). The period was calculated between days 8
and 21 in DD. (C) Period-length quantification of C57BL/6J-backcrossed wild
type (WT), Rev-erbα−/−, Fbxl3−/−, and Fbxl3−/−;Rev-erbα−/− mice. Bars indicate
the mean ± SD. Statistical significance was set at P < 0.05, as determined by
one-way ANOVA followed by Tukey’s post hoc test. *P < 0.05, **P < 0.01. Total 
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Fig. 2. Impaired CRY1 and BMAL1 accumulation in Fbxl3-/− and Fbxl3−/−;
Rev-erbα−/− liver tissues. (A and C) Protein oscillation profiles of BMAL1 and
CRY1 in total extracts from wild-type and Fbxl3−/− (A) and wild-type and
Fbxl3−/−;Rev-erbα−/− liver tissues (C). Samples and blots were processed in
parallel in paired experiments and exposed on the same film. Each figure
shows a representative example from three independent experiments. All
tissues were collected at 4-h intervals during the first day in constant darkness
(thereafter). Gray bars represent subjective day, and black bars represent
subjective night. Actin served as the loading control (B and D). Quantification
of BMAL1 and CRY1 in the total extracts from the wild-type (blue line) and
Fbxl3−/− (red line) (B) and wild-type (blue line) and Fbxl3−/−;Rev-erbα−/− (red
line) liver tissues (D) using National Institutes of Health ImageJ. Data were
taken from three independent experiments. Bars indicate the mean ± SD.
Two-way ANOVA showed significant statistical differences between WT and
Fbxl3−/− mice for CRY1 (P < 0.01) and between WT and Fbxl3−/−;Rev-erbα−/−
mice for BMAL1 (P < 0.01) and CRY1 (P < 0.05) in liver tissues.
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Bmal1, Cry1, Per1, and Per2 over a circadian cycle in these mutant
liver tissues (Fig. 4A) and found near-constant and high Bmal1
expression levels in Fbxl3−/−;Rev-erbα−/− mice and similar levels
in Rev-erbα−/− liver tissues. In addition, the phase of the Cry1
mRNA rhythm was also dramatically advanced in Fbxl3−/−;Rev-
erbα−/− mice compared with the Fbxl3−/− mice. Furthermore, the
amplitudes of the Per1 and Per2 mRNAs were attenuated to a
similar extent in Fbxl3−/−;Rev-erbα−/− and Fbxl3−/− liver (Fig. 4A).
These results were consistent with the similar enhancement
of CRY1 binding to the E-box regions in both mutant mice
(Fig. 3A), suggesting that the enhanced suppression of E-box–
driven transcription in the Fbxl3−/− mice was not rescued in the
Fbxl3−/−;Rev-erbα−/− double-mutant mice.
To determine whether the effects of FBXL3 on the E-box–
mediated transcriptional inhibition were dependent on the CRY
proteins, we generated Fbxl3−/−;Cry1−/− double-mutant mice and
profiled the mRNA levels of Per1 and Per2 in the livers. Unlike
the Fbxl3−/− single-mutant mice and the Fbxl3−/−;Rev-erbα−/−
mice, the circadian amplitudes of the E-box–driven transcripts
in the Fbxl3−/−;Cry1−/− liver tissues were all restored to levels
comparable with those in wild-type tissues (Fig. 4B). These re-
sults suggest that the role of FBXL3 in regulating the amplitude
of circadian clock is mainly through its action on CRY1.
To further evaluate the contribution of CRYs to the long-
period phenotype of the Fbxl3−/− mice, we determined the lo-
comotor activities of the Fbxl3−/−;Cry1−/− and Fbxl3−/−;Cry2−/−
double-mutant mice. Consistent with a previous report (18, 19),
Cry1−/− mice displayed a period length of 22.5 ± 0.3 h, whereas
the Cry2−/− mice had a period of 24.5 ± 0.3 h. The period lengths
were predicated to be ∼26.4 h and ∼28.4 h for the Fbxl3−/−;Cry1−/−
and Fbxl3−/−;Cry2−/− double-mutant mice, respectively, if there are
no genetic interactions between FBXL3 and the CRYs. The ob-
served period for the Fbxl3−/−;Cry2−/− double-mutant mice (28.2 ±
0.1 h) was very close to the predicted period, suggesting a lack of
genetic interaction for the period determination between these
two genes (Fig. 4C). However, the Fbxl3−/−;Cry1−/− double-
mutant mice had a 24.3 ± 0.4 h period (Fig. 4C), suggesting that
the long-period phenotype of the Fbxl3 mutant was only partially
dependent on Cry1 (Cry1−/− mice: 22.5 ± 0.3 h).
Fbxl3 Deficiency Is Associated with Retention of HDAC3 Complexes at
RRE Sites. The rescue of the Fbxl3−/− circadian period length by the
deletion of Rev-Erbα suggested that Rev-Erbα may act down-
stream of FBXL3 (21). We thus examined the Rev-erbα mRNA
and the Rev-Erbα protein profiles in the Fbxl3−/− liver tissues. In
agreement with previous observations (8, 22), the levels ofRev-erbα
mRNA and Rev-Erbα protein exhibited robust circadian rhythms
in wild-type tissues (Fig. 5A andB).We observed reduced levels of
Rev-erbα mRNA in Fbxl3−/− mice. Correspondingly, the peak
abundance of Rev-Erbα protein were also reduced; however, the
protein accumulation pattern was remarkable altered as Rev-Erbα
protein could be detected at the points when it was not present
under normal circumstances (Fig. 5B), indicating that the loss of
Fbxl3 may impair the clearance of the Rev-Erbα protein.
Rev-Erbα was shown to recruit HDAC3-containing complexes
to RREs to repress transcription (23, 24). The impaired clearance
of Rev-Erbα in the Fbxl3−/− mice prompted us to investigate the
recruitment of HDAC3 to the RREs by ChIP. As shown in Fig.
5C, the binding of HDAC3 to the Bmal1 RRE showed a robust
rhythm in wild-type liver samples, with peak levels occurring from
CT8 to CT16. In the Fbxl3−/− mice, however, HDAC3 binding
persisted at high levels in this region from CT12 to CT24 (Fig.
5C). Similar results were observed for the RRE of Cry1 (Fig.
5D), suggesting that the RREs of both Cry1 and Bmal1 are reg-
ulated by a similar mechanism. Moreover, HDAC3 binding was
virtually absent from the RRE regions in either the Rev-erbα−/− or
Fbxl3−/−; Rev-erbα−/− mice (Fig. 5 C and D), consistent with the
observation that Rev-Erbα was required for recruitment of the
repressor complex at these RRE loci (24). These data suggested
that loss of Fbxl3 leads to impaired clearance of Rev-Erbα and
retention of HDAC3 at the RREs.
FBXL3 Regulates the Rev-Erbα:HDAC3 Mediated Suppression. The
above results suggested that the presence of FBXL3 may regulate
Rev-Erbα:HDAC3 activity on the RRE. To determine whether
FBXL3 is a component of the Rev-Erbα:HDAC3 complex, we
examined the interaction of endogenous FBXL3 and Rev-Erbα
by co-IP experiments. We found that FBXL3 can interact with
Rev-Erbα under physiological conditions (Fig. 6A). To determine
whether FBXL3 could be recruited directly to the RRE region
together with Rev-Erbα, we performed an in vitro protein–DNA
binding assay. Streptavidin magnetic beads with tethered con-
catemers containing the RRE sequence were incubated with cell
extracts from human embryonic kidney 293T cells expressing Myc-
tagged FBXL3 with or without HA-tagged Rev-Erbα. The purified
RRE-binding proteins were then analyzed by Western blotting
(WB). As shown in Fig. 6B, FBXL3 associated with the RRE
oligonucleotide-coupled beads only in the presence of Rev-Erbα,
and FBXL3 did not affect the ability of Rev-Erbα to bind DNA,
suggesting that Rev-Erbα mediates the recruitment of FBXL3
to RREs. Finally, to analyze whether FBXL3 regulates the
transcriptional suppression function of the HDAC3:Rev-Erbα
complex, we examined the ability of FBXL3 to regulate a Bmal1
promoter-driven luciferase reporter. As shown in Fig. 6C, the
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Fig. 3. Altered CRY1 binding to the E-box regions in Fbxl3-/−and Fbxl3−/−;Rev-erbα−/− liver tissues. (A) CRY1 binding to the E-box regions of the Cry1 and Per2
promoter/enhancer loci across a circadian cycle (mean ± SD, n = 3). IgG served as an internal control. RRE site in the first intron of Cry1 from wild-type samples
served as the negative control locus (data not shown). Chromatin samples from the livers of wild-type (blue), Fbxl3−/− (red) and Fbxl3−/−;Rev-erbα−/− (purple)
mice were analyzed by ChIP (each time point represents an average of three to four mice for each genotype). Two-way ANOVA demonstrated significant
statistical differences between the WT and Fbxl3−/− and WT and Fbxl3−/−;Rev-erbα−/− liver tissues for CRY1 binding. Differences between the Fbxl3−/− and
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blotted using anti-FBXL3 or anti-CRY1 antibodies. CRY1 profiles in wild-type tissues (Fig. 2A, Middle) and FBXL3 profile (Fig. 3B) served as input. Actin served
as the tissue lysate control.
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expression of HDAC3 significantly augmented the Rev-Erbα–
mediated inhibition of Bmal1 promoter activity (lane 3 vs. 9). The
coexpression of FBXL3 blocked this effect (Fig. 6C, lane 9 vs. 10),
indicating that FBXL3 inhibits the repressor activity of the Rev-
Erbα:HDAC3 complex. The effect of FBXL3 was abolished when
the RRE sites on the Bmal1 promoter were mutated (25) (Fig.
6C), indicating that the RRE sites are necessary for FBXL3-
mediated transcriptional regulation and that FBXL3 acts by
targeting the RRE-associated Rev-Erbα:HDAC3 complex.
Discussion
Forward and reverse genetic studies have successfully discovered
many key molecular components of the mammalian circadian
clock (8, 11, 12, 15, 16, 26, 27). However, the genetic deletion
of individual core clock components, including Per1, Per2, Cry1,
Cry2, Clock, and Rev-erbα, resulted in only modest (1–2 h) period
changes (8, 18, 19, 26, 28, 29), suggesting that the mammalian
clock functions as a network to maintain its periodicity and ro-
bustness. In the past, efforts have been made to analyze circadian
phenotypes by disrupting paralogous clock genes such as Cry1/2,
Per1/2, and Rev-erbα/β in mice (22, 26, 30, 31). Cry/Per double-
mutant mice have also been analyzed (32). The inactivation of
two or more clock components provides unique insights into the
genetic mechanisms of circadian rhythms. In this report, we tested
genetic interactions between different clock mutant mice without
preconceived ideas about the roles of these genes in the circadian
network. Although most of the double mutants we generated were
functionally independent, we found a strong genetic interaction
between Fbxl3 and Rev-erbα, which led us to uncover an important
role of Fbxl3 in regulating the Rev-Erbα:HDAC3 complex.
Previous studies showed that FBXL3 mediated the degradation
of CRY (11, 13) and our findings further suggest that FBXL3 plays
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gene expression and locomotor in the Fbxl3-deficient background. (A) Ex-
pression of the Bmal1, Cry1, Per2, and Per1 clock genes in liver tissues of
wild-type (blue), Fbxl3−/− (red), Rev-erbα−/− (green), and Fbxl3−/−;Rev-erbα−/−
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sents the mean ± SD (n = 3). Two-way ANOVA demonstrated significant
statistical differences among the WT, Fbxl3−/−, and Fbxl3−/−;Rev-erbα−/− liver
tissues for the expression of Bmal1, Cry1, Per1, and Per2 (P < 0.01). (B) mRNA
levels of Per1 and Per2 in the livers of wild-type (blue), Fbxl3−/− (red), and
Fbxl3−/−;Cry1−/− (green) mice were measured by quantitative RT-PCR. Two-
way ANOVA demonstrated significant statistical differences among the WT,
Fbxl3−/−, and Fbxl3−/−;Cry1−/− liver tissues for the expression of Per1 and
Per2 (P < 0.01). (C) Representative actograms from Fbxl3−/−;Cry1−/− (n = 8)
and Fbxl3−/−;Cry2−/− (n = 6) mice.
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Fig. 5. Impaired HDAC3 clearances from the RRE sites in Fbxl3−/− mice. (A)
Quantitative analysis of the Rev-Erbα mRNA levels in the livers of wild-type
and Fbxl3−/− mice. Relative levels of RNA were estimated by quantitative RT-
PCR and normalized to Gapdh. Data represent the mean ± SD (n = 3). (B)
Representative circadian profiles of Rev-Erbα protein in the liver of wild-type
and Fbxl3−/− mice. Rev-Erbα protein was detected with an anti–Rev-Erbα
antibody after IP with anti–Rev-Erbα serum. No signal after prolonged ex-
posure could be detected from CT16 to CT24 in wild-type liver tissues. Actin
served as control. (C and D) Altered HDAC3 binding to the RRE regions in the
Bmal1 (C) and Cry1 promoter/enhancer locus (D) (mean ± SD, n = 3). Each
figure shows a representative example from three independent experi-
ments. Two-way ANOVA demonstrated significant statistical differences
between theWT and Fbxl3−/−, WT and Fbxl3−/−;Rev-erbα−/−, and Fbxl3−/− and
Fbxl3−/−;Rev-erbα−/− liver tissues for HDAC3 binding. Notably, the differ-
ences in HDAC3 binding between Rev-erbα−/− and Fbxl3−/−;Rev-erbα−/− samples
were abolished (P > 0.05). *P < 0.05, **P < 0.01.
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an important role in controlling CRY1 binding to chromatin in
a rhythmic manner. In the Fbxl3−/− and Fbxl3−/−;Rev-erbα−/−
mice, the increased binding of the CRY1 protein to the E-box
regions of the Per2 and Cry1 genes was observed from CT12 to
CT20, at which the FBXL3 and CRY1 interaction could barely
be detected in wild-type mice (Fig. 3B). Furthermore, the E-box–
driven transcription of Per1 and Per2 exhibited similar low-
amplitude rhythms in Fbxl3−/− and Fbxl3−/−;Rev-erbα−/− liver
tissues. In addition, we assayed Per1 and Per2 mRNA profiles
in the cerebellum. As described previously (11), the expression
levels were reduced to a larger extent in Fbxl3−/− and Fbxl3−/−;
Rev-erbα−/− mice (Fig. S7). We do not exclude the possibility
that tissue-specific regulators also play an important role in
attaining the robustness of the clock. However, these results are
not in conflict with the notion that FBXL3 facilitates depletion
of CRY1 from E-box, and deletion of Rev-erbα has less effort
on the amplitudes of Per1 and Per2 expression. Importantly, the
deletion of Cry1 in an Fbxl3-null background appeared to restore
the levels of Per1 and Per2 transcription and partially rescued
its period length. Taken together, these observations indicate
that the impairment of CRY degradation on chromatin can ac-
count for the dampened E-box–driven transcription and part of
the long-period phenotype of the Fbxl3−/− mice.
We found that the deletion of Rev-erbα rescued the very-long-
period phenotype caused by Fbxl3 deficiency, indicating a genetic
interaction between these two genes. We examined the re-
lationship between Fbxl3 and Rev-erbα in these mutant mice and
found that the expression of Rev-erbα was dramatically reduced
in the Fbxl3−/− mice (Fig. 5A), whereas the clearance of Rev-
Erbα protein is impaired. The deletion of Fbxl3 results in in-
creased HDAC3 binding at the RRE regions and deletion of
Rev-erbα abolishes the retention of HDAC3 (Fig. 5 C and D). In
addition, FBXL3 was also found to alleviate HDAC3 repression
for a Bmal1 RRE reporter (Fig. 6C). These results suggested
that FBXL3 directly regulates the RRE-mediated transcription
by regulating the Rev-Erbα:HDAC3 complex, providing a mo-
lecular explanation for the genetic interaction between FBXL3
and Rev-Erbα. Therefore, FBXL3 serves as a critical regulatory
link between the negative and positive circadian feedback loops.
Previous synthetic promoter studies showed that RREs, E/E′
boxes, and D boxes work in a coordinated fashion to generate
substantial phase delay during circadian oscillation that is im-
portant for establishing a normal circadian period (33, 34). Our
results provided genetic evidence that: (i) deletion of Fbxl3
impairs the amplitudes of E-box–driven gene transcription, (ii)
the abnormal retention of HDAC3 further contributes to a phase
delay in the RRE-mediated transcriptional expression. We thus
proposed that suppression at both E-boxes and RREs in the
Fbxl3−/− mice may contribute to its extremely long period length
(Fig. 6D). This work highlights the important role of FBXL3 in
connecting two circadian feedback loops and suggests that the
proper control and balance of transcriptional activity at the E-boxes
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Fig. 6. FBXL3 regulates Rev-Erbα:HDAC3 complex-mediated suppression.
(A) Coimmunoprecipitation of FBXL3 and Rev-Erbα in liver tissues at zeitgeber
time (ZT)11. Immunoprecipitates of Rev-Erbα from the wild-type and Rev-erbα
knockout (KO) liver tissues were probed with the FBXL3 (Left) and Rev-Erbα
(Right) antibodies. Actin served as a control for protein amount. (B) DNA (RRE)-
conjugated magnetic beads were incubated with cell lysates containing FBXL3
and/or HA–Rev-Erbα. FBXL3 and HA–Rev-Erbα were detected by WB of
the eluants. NC, negative control (nonrelated oligo-DNA); RRE, oligo-DNA
containing RRE sequences. (C ) Effects of FBXL3 on the Rev-Erbα:HDAC3
complex-mediated suppression of Bmal1 promoter-driven luciferase. Bar
graphs depict the relative luciferase activities (mean ± SD) from three
independent experiments. Statistical analysis was performed using one-way
ANOVA followed by Tukey’s test. **P < 0.01. A total of 251 ng DNA containing
50 ng of each vector together with 1 ng of renilla luciferase expressing vector
was transfected into U2OS (a human osteosarcoma cell line) cells. Luciferase
activity was measured using the dual-luciferase report assay system. (Left)
Bmal1 promoter with wild-type RRE. (Right) Bmal1 promoter containing the
mutant RRE as previously described (25). (D) Model illustrating FBXL3 on
E-box and RRE codependency for effective circadian period determination.
FBXL3 releases E-box repressor complexes through degradation of chromatin
on CRY1. It also removes repressors at the RRE sites. Inhibition duration by
E-box and RRE-regulated complexes on these elements may regulate circa-
dian period. BMAL1 (B), CLOCK (Clk), FBXL3 (F), HDAC3 (H), Rev-Erbα (RV),
Rorα (R), and nuclear receptors (NR).
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of Pers/Crys and RREs of Bma1/Crys contribute significantly to
the period determination of the clock in mammals.
Materials and Methods
Generation of Single- and Double-Mutant Mice. Clock mutant mice (15) and
Overtime mice (11) were obtained from the J.S. Takahashi laboratory at
Northwestern University, Evanston, IL. Rev-Erbα knockout mice (8) were
obtained from the Ueli Schibler laboratory at the University of Geneva, Geneva.
For the conditional Fbxl3 knockout mice, the targeting vector was constructed
(Fig. S2). The Cry1−/− and Cry2−/− mice were generated as previously reported
(18, 19). Briefly, a LacZ-neo cassette was used to replace exons 6–10 of Cry1 and
exons 6–11 of Cry2 in the targeting vectors. Other single-mutant mice used in
these studies have been described previously (27, 35).
Animal Care and Behavioral Analysis. All of the animals were backcrossed at
least five generations before the first pilot study to assure a largely C57BL/6J
background. Measurements of the free running period were performed as
previously described (27). We used the formula τpredicted = τx + τy − τwild type
(x and y represent different single-mutant mice, respectively) to predict τ of
the double-mutant mice. This formula was proposed based on the assump-
tion that there is no genetic interplay between the different mutations.
Therefore, if the experimental period is close to the predicted value, the two
tested mutations are very likely to function independently of each other.
All animal studies were carried out in an Association for Assessment and
Accreditation of Laboratory Animal Care International accredited SPF animal
facility, and all animal protocols were approved by the Animal Care and Use
Committee of the Model Animal Research Center, Nanjing University.
Antibodies, Western Blotting, Coimmunoprecipitation, and Chromatin
Immunoprecipitation. Anti-BMAL1, anti-CRY1, and anti-FBXL3 antibodies were
generated using synthetic peptides as immunogens (Signalway Antibody). Pep-
tide sequences for each antibody were as follows (underline represents amino
acid sequences for each antibody): BMAL1, CSSSILGENPHIGIDMIDNDQGSSSPS-
NDEA; CRY1, CSQGSGILHYAHGDSQQTHSLKQGRSSAGTG; and FBXL3, CMKRG-
GRDSDQDSAEEGTAEKPKRPRTTQRE. Anti–Rev-Erbα serum was also generated
by immunizing rabbits with purified protein corresponding to the N-terminal
126 AA of mouse Rev-Erbα. Antibodies against the following proteins were
obtained from the indicated suppliers: HDAC3 (Santa Cruz; sc11417) and
Rev-Erbα (Cell Signaling; 2124). The coimmunoprecipitation experiments
were performed as previously described (36) using mouse liver extracts.
For the detection of Rev-Erbα, the liver extracts were immunopreci-
pitated with the antiserum and then immunoblotted with antibodies
purchased from Cell Signaling as described above. For the detection of
FBXL3, the liver extracts were immunoprecipitated and immunoblotted with
the same antibody.
ChIP assays were performed as described previously (36), except that hy-
potonic buffer (Active Motif; 100505) was used to obtain the nuclear extracts.
Rabbit IgGs from nonimmunized rabbits were used as the negative control.
For ChIP on E-box sites (at the Cry1 and Per2 promoter), the first intron of
Cry1 was used as the control locus: for ChIP on RRE sites (at the Bmal1 and
Cry1 promoter/enhancer), the Cry1 promoter was used as the control site. All
of the primers were validated for SYBR-based real-time PCR (Table S1).
Tissue Collection, RNA Isolation, RT-PCR, and mRNA Expression Analyses. Tissue
collection, RNA isolation and RT-PCR were carried out as previously described
(27). Details are available in SI Text.
In Vitro DNA-Mediated Pull Down. Details are available in SI Text.
Statistical Analyses. One-way or two-way analysis of variance (ANOVA) fol-
lowed by the Tukey test was performed for multiple group comparisons using
Graphpad Prism software to determine the significant differences between
different genotypes. P < 0.05 was considered statistically significant.
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